These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18172042)

  • 41. [Therapy of cardiac insufficiency: clinical trial of the cardiotonic agent deglucolanatoside C].
    Soubihe NV; Mesquita JR; Zedú N
    Arq Bras Cardiol; 1971 Feb; 24(1):25-31. PubMed ID: 4941641
    [No Abstract]   [Full Text] [Related]  

  • 42. Prognostic factors affecting the all-cause death and sudden cardiac death rates of post myocardial infarction patients with low left ventricular ejection fraction.
    Dai SM; Zhang S; Chen KP; Hua W; Wang FZ; Chen X
    Chin Med J (Engl); 2009 Apr; 122(7):802-6. PubMed ID: 19493393
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Relevancy of sudden death of cardiac origin].
    Báyes de Luna A; Kotzeva A; Goldwasser D; Subirana M; Puig MT; Bayés-Genis T; Cinca J; Vázquez R
    Arch Cardiol Mex; 2007; 77 Suppl 4():S4-123-8. PubMed ID: 18938710
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Heart hypertrophy and heart failure--experimental findings for arrhythmogenesis].
    Milberg P; Pott C; Eckardt L; Breithardt G
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S285-9. PubMed ID: 19085808
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Venous thromboembolism prophylaxis in hospitalized heart failure patients.
    Jois-Bilowich P; Michota F; Bartholomew JR; Glauser J; Diercks D; Weber J; Fonarow GC; Emerman CL; Peacock WF;
    J Card Fail; 2008 Mar; 14(2):127-32. PubMed ID: 18325459
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictive value of cardiac autonomic indexes and MIBG washout in ICD recipients with mild to moderate heart failure.
    Koutelou M; Katsikis A; Flevari P; Theodorakis G; Livanis E; Georgiadis M; Voudris V; Kremastinos D
    Ann Nucl Med; 2009 Sep; 23(7):677-84. PubMed ID: 19662346
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of risk profiles between survivors and victims of sudden cardiac death from an acute coronary event.
    Kaikkonen KS; Kortelainen ML; Huikuri HV
    Ann Med; 2009; 41(2):120-7. PubMed ID: 18720091
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary heart disease: a meta-analysis of randomized controlled trials.
    Zhao YT; Chen Q; Sun YX; Li XB; Zhang P; Xu Y; Guo JH
    Ann Med; 2009; 41(4):301-10. PubMed ID: 19148838
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sudden cardiac death in China.
    Zhang S
    Pacing Clin Electrophysiol; 2009 Sep; 32(9):1159-62. PubMed ID: 19719492
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cocaine cardiotoxicity: a review of the pathophysiology, pathology, and treatment options.
    Phillips K; Luk A; Soor GS; Abraham JR; Leong S; Butany J
    Am J Cardiovasc Drugs; 2009; 9(3):177-96. PubMed ID: 19463023
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sudden cardiac death in pediatrics.
    Bar-Cohen Y; Silka MJ
    Curr Opin Pediatr; 2008 Oct; 20(5):517-21. PubMed ID: 18781113
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial.
    Massie BM; Collins JF; Ammon SE; Armstrong PW; Cleland JG; Ezekowitz M; Jafri SM; Krol WF; O'Connor CM; Schulman KA; Teo K; Warren SR;
    Circulation; 2009 Mar; 119(12):1616-24. PubMed ID: 19289640
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Meta-analysis of prognostic value of stress testing in patients with asymptomatic severe aortic stenosis.
    Rafique AM; Biner S; Ray I; Forrester JS; Tolstrup K; Siegel RJ
    Am J Cardiol; 2009 Oct; 104(7):972-7. PubMed ID: 19766766
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Long-term antithrombotic therapy for the prevention of thromboembolic complications in patients with chronic heart failure].
    Osmolovskaia IuF; Romanova NV; Zhirov IV; Tereshchenko SN
    Kardiologiia; 2014; 54(6):86-90. PubMed ID: 25178085
    [No Abstract]   [Full Text] [Related]  

  • 55. [Moduretic in the treatment of cardiac failure].
    Nordlie KE; Søiland C
    Tidsskr Nor Laegeforen; 1981 Jun; 101(16):996-1001. PubMed ID: 7025344
    [No Abstract]   [Full Text] [Related]  

  • 56. The dilemma of thromboembolism prophylaxis in patient with acute heart failure.
    Taveras Hiraldo A
    Int J Cardiol; 2023 Mar; 375():55-56. PubMed ID: 36535561
    [No Abstract]   [Full Text] [Related]  

  • 57. Anticoagulation, atherosclerosis, and heart failure.
    Agewall S
    Eur Heart J Cardiovasc Pharmacother; 2017 Jan; 3(1):1-2. PubMed ID: 28062653
    [No Abstract]   [Full Text] [Related]  

  • 58. Letter by Pascual-Figal et al regarding article, "Anabolic deficiency in men with chronic heart failure: prevalence and detrimental impact on survival".
    Pascual-Figal DA; Tornel PL; Valdes M
    Circulation; 2007 May; 115(21):e548; author reply e549. PubMed ID: 17533191
    [No Abstract]   [Full Text] [Related]  

  • 59. [Use of methylprednisolone in patients with circulatory failure].
    Ashbel' SI; Reznik ND; Vladyko NV
    Klin Med (Mosk); 1985 Aug; 63(8):111-4. PubMed ID: 3908803
    [No Abstract]   [Full Text] [Related]  

  • 60. [On the use of desacetyl-lanatoside C in therapy of uncompensated heart diseases. Clinical contribution].
    Vercillo L; Rossi C; Vergallo L
    Minerva Med; 1965 Sep; 56(74):3172-5. PubMed ID: 5319422
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.